Ratings by Lake Street (Daniel Brims)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/17/2026 | Kyntra Bio | KYNB | New Coverage | Buy (N/A) |
7.61 (6.94) |
-8.8% | Details | |
| 9/17/2026 | Spruce Biosciences, Inc. | SPRB | New Coverage | Buy (N/A) |
54.16 (48.72) |
-10.04% | Details | |
| 5/28/2026 | Viking Therapeutic | VKTX | New Coverage | Buy (N/A) |
31.66 (35.56) |
12.32% | Details | |
| 5/28/2026 | Aligos Therapeutics Inc. | ALGS | New Coverage | Buy (N/A) |
5.60 (5.51) |
-1.61% | Details | |
| 4/14/2026 | Kura Oncology | KURA | New Coverage | Buy (N/A) |
8.72 (10.76) |
23.39% | Details | |
| 4/14/2026 | Rani Therapeutics | RANI | New Coverage | Buy (N/A) |
0.78 (0.76) |
-2.56% | Details |
